CLSI M59
Epidemiological Cutoff Values for Antifungal Susceptibility Testing, 2nd Edition, M59Ed2E
standard by Clinical and Laboratory Standards Institute, 01/01/2018
Side Navigation
X
CLSI EP31-A-IR (R2018)
Verification of Comparability of Patient Results Within One Health Care System; Approved Guideline, EP31AIRE
standard by Clinical and Laboratory Standards Institute, 08/01/2012
CLSI POCT12-A3 (R2018)
Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities; Approved Guideline, Third Edition, POCT12A3E
standard by Clinical and Laboratory Standards Institute, 01/01/2013
CLSI M02-Ed13 and M100-Ed28 Package
Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard – Thirteenth Edition/Performance Standards for Antimicrobial Susceptibility Testing, Twenty-Eighth Informational Supplement, M02Ed13E, M100Ed28E
standard by Clinical and Laboratory Standards Institute, 01/01/2018
CLSI H22P
Histochemical Method for Leukocyte Alkaline Phosphatase; Proposed Standard, H22-P
standard by Clinical and Laboratory Standards Institute, 10/01/1984
CLSI MM19-A
Establishing Molecular Testing in Clinical Laboratory Environments; Proposed Guideline, MM19AE
standard by Clinical and Laboratory Standards Institute, 11/01/2011
CLSI T/DM08A
Urine Drug Testing in the Clinical Laboratory; Approved Guideline, T/DM08-A
standard by Clinical and Laboratory Standards Institute, 02/01/1999
CLSI H15-A3
Reference and Selected Procedures for the Quantitative Determination of Hemoglobin in Blood; Approved Standard, H15-A3
standard by Clinical and Laboratory Standards Institute, 12/01/2000
CLSI C49
Analysis of Body Fluids in Clinical Chemistry, 2nd Edition, C49Ed2E
standard by Clinical and Laboratory Standards Institute, 11/13/2018
CLSI EP24-A2 (R2018)
Assessment of the Diagnostic Accuracy of Laboratory Tests Using Receiver Operating Characteristic Curves; Approved Guideline – Second Edition, EP24A2E
standard by Clinical and Laboratory Standards Institute, 11/30/2011